AC Immune SA (ACIU) Misses Q4 EPS by 56c

AC Immune SA (NASDAQ: ACIU) reported Q4 EPS of ($0.81), $0.56 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $3.94 million versus the consensus estimate of $1.6 million.

For earnings history and earnings-related data on AC Immune SA (ACIU) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• AC Immune Receives FDA Fast Track Designation for Anti-Alpha-synuclein Active Immunotherapy, ACI-7104, to Treat Early Parkinson’s Disease (PD)